09/03/2024 3:48 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 1:05 PM | Johnson & Johnson (Filer)
| Form N-PX Annual Report of Proxy Voting Record of Registered Management Investment Company | |
08/26/2024 3:26 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2024 3:35 PM | Johnson & Johnson (Filer)
| Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
07/30/2024 8:06 PM | Johnson & Johnson (Filed by) Rallybio Corp (Subject)
| Form SC 13G | |
07/25/2024 3:02 PM | Johnson & Johnson (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/17/2024 7:14 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
07/09/2024 4:48 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:18 PM | Johnson & Johnson (Filer)
| Form 11-K/A | |
06/24/2024 3:43 PM | Johnson & Johnson (Filer)
| Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/24/2024 3:42 PM | Johnson & Johnson (Filer)
| Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/06/2024 4:07 PM | HEWSON MARILLYN A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 4:07 PM | Johnson & Johnson (Issuer) Woods Eugene A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:10 PM | Johnson & Johnson (Filer)
| Form SD Specialized Disclosure Report | |
05/21/2024 9:43 AM | Johnson & Johnson (Filer)
| Form CERT | |
05/20/2024 4:17 PM | Johnson & Johnson (Filed by) Kenvue Inc. (Subject)
| Form SC 13G/A | |
05/20/2024 3:34 PM | Johnson & Johnson (Filer)
| Form 8-A12B | |
05/20/2024 8:31 AM | Johnson & Johnson (Subject) NEW YORK STOCK EXCHANGE LLC (Filed by)
| Form 25-NSE | |
05/17/2024 10:21 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 5:05 AM | Johnson & Johnson (Filer)
| Form 424B5 | |
05/13/2024 7:36 AM | Johnson & Johnson (Filer)
| Form 424B5 | |
05/10/2024 4:14 PM | Johnson & Johnson (Filer)
| Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
05/01/2024 6:00 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2024 6:09 AM | Johnson & Johnson (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 4:05 PM | Doudna Jennifer A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:05 PM | Johnson & Johnson (Issuer) Johnson Paula A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:05 PM | Johnson & Johnson (Issuer) Joly Hubert (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | Johnson & Johnson (Issuer) McClellan Mark B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | Johnson & Johnson (Issuer) WEINBERGER MARK A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | Johnson & Johnson (Issuer) MULCAHY ANNE M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | Johnson & Johnson (Issuer) Woods Eugene A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | Adamczyk Darius (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | Johnson & Johnson (Issuer) West Nadja (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | HEWSON MARILLYN A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | Beckerle Mary C (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 11:16 AM | Johnson & Johnson (Filer)
| Form 8-K/A | |
04/16/2024 6:06 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 4:05 PM | Contineum Therapeutics, Inc. (Issuer) Johnson & Johnson (Reporting) Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/10/2024 4:12 PM | Contineum Therapeutics, Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G | |
04/05/2024 4:29 PM | Johnson & Johnson (Filed by) Shockwave Medical, Inc. (Subject)
| Form DFAN14A | |
03/27/2024 8:48 AM | Johnson & Johnson (Subject) National Legal & Policy Center (Filed by)
| Form PX14A6G | |
War on Elon Escalates… (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9244&Placement=NativeDisplay&Source=NativeDisplay) One company holds a near-total monopoly on it. |
03/13/2024 3:28 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024 3:36 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 6:42 AM | Johnson & Johnson (Filer)
| Form ARS | |
03/13/2024 6:35 AM | Johnson & Johnson (Filer)
| Form DEF 14A | |
03/13/2024 6:37 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
03/13/2024 6:39 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
03/06/2024 2:42 PM | CVRx, Inc. (Issuer) Johnson & Johnson (Reporting) Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:58 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:54 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:12 PM | Johnson & Johnson (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 4:23 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
02/15/2024 3:53 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Wengel Kathryn E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Swanson James D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Wolk Joseph J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Johnson & Johnson (Issuer) Swanson James D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Wolk Joseph J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Wengel Kathryn E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 11:55 AM | Johnson & Johnson (Subject) McEvoy Ashley (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 11:35 AM | Johnson & Johnson (Subject) Taubert Jennifer L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2024 3:24 PM | Johnson & Johnson (Subject) McEvoy Ashley (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 4:07 PM | BiomX Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G/A | |
02/02/2024 3:52 PM | CVRx, Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G/A | |
02/02/2024 3:32 PM | Johnson & Johnson (Filed by) Johnson & Johnson (Filed by) Nanobiotix S.A. (Subject)
| Form SC 13G/A | |
01/30/2024 11:46 AM | Johnson & Johnson (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/29/2024 3:50 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/24/2024 11:51 AM | Johnson & Johnson (Filed by) Kenvue Inc. (Subject)
| Form SC 13G | |
01/23/2024 6:45 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Who are Nvidia’s New Silent Partners? (Ad) Nvidia recently became just the third $2 trillion company.
But Nvidia can’t do everything by itself.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9286&Placement=NativeDisplay&Source=NativeDisplay) I call these Nvidia’s “Silent Partners.” |
01/09/2024 4:08 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/08/2024 4:22 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/08/2024 7:22 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
12/08/2023 3:33 PM | Johnson & Johnson (Issuer) Woods Eugene A. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/07/2023 4:17 PM | HEWSON MARILLYN A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:42 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 6:52 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/30/2023 3:30 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2023 3:56 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |